Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Stephens

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2017
<sup>18</sup>F-Florbetaben PET beta-amyloid binding expressed in CentiloidsChristopher C Rowe, Vincent Doré, Gareth Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Tumor targeting by an aptamerBrian J Hicke, Andrew W Stephens, Ty Gould, et al.
Nuclear Medicine and Biology|July 23, 2019
Radiation dosimetry of [<sup>18</sup>F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolismNarae Lee, Inhye Oh, Sun Young Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid TumorsValentine M Macaulay, Mark R Middleton, S Gail Eckhardt, et al.
EJNMMI Research|August 29, 2020
Initial evaluation of (4S)-4-(3-[<sup>18</sup>F]fluoropropyl)-L-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphomaSonya Y Park, Camila Mosci, Meena Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of ThrombiJessica Lohrke, Holger Siebeneicher, Markus Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumorsRobin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Molecular Imaging and Biology|September 29, 2016
Utility of [<sup>18</sup>F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US PopulationGina Kavanaugh, Jason Williams, Andrew Scott Morris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 24, 2022
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic settingIngrid S van Maurik, Hana M Broulikova, Arenda Mank, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2017
<sup>18</sup>F-Florbetaben PET beta-amyloid binding expressed in CentiloidsChristopher C Rowe, Vincent Doré, Gareth Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Tumor targeting by an aptamerBrian J Hicke, Andrew W Stephens, Ty Gould, et al.
Nuclear Medicine and Biology|July 23, 2019
Radiation dosimetry of [<sup>18</sup>F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolismNarae Lee, Inhye Oh, Sun Young Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid TumorsValentine M Macaulay, Mark R Middleton, S Gail Eckhardt, et al.
EJNMMI Research|August 29, 2020
Initial evaluation of (4S)-4-(3-[<sup>18</sup>F]fluoropropyl)-L-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphomaSonya Y Park, Camila Mosci, Meena Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of ThrombiJessica Lohrke, Holger Siebeneicher, Markus Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumorsRobin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Molecular Imaging and Biology|September 29, 2016
Utility of [<sup>18</sup>F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US PopulationGina Kavanaugh, Jason Williams, Andrew Scott Morris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 24, 2022
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic settingIngrid S van Maurik, Hana M Broulikova, Arenda Mank, et al.
Pageof 8